NCT00402584View on ClinicalTrials.gov

A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

August 31, 2000

Conditions
Binge Eating DisorderObesity
Interventions
DRUG

sibutramine

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY